What You Need to Know About High Times’ Public Stock Offering

While capital continues to flow into cannabis companies, iconic ’70s stoner company High Times has stepped up with a Reg A+ public stock offering to raise money under the 2012 US Jobs Act.

The deal faces a healthy dose of risk since High Times remains deeply in debt as it seeks to grow its events business and reverse a decline in its magazine and other publishing units.

In an Aug. 3 press release, High Times said it would accept Bitcoin payments for potential investors to buy stock. But in an Aug. 13 filing with regulators, High Times admitted the release was distributed in error and that it would not take Bitcoin as payment for shares. The company did not elaborate on how the mistake was made or why it would not accept Bitcoin.

However, High Times continues to accept checks, credit cards, ACH or wire transfers as payment for subscription to is Reg-A+ share offering.

While High Times is allowed to raise up to $50 million under Reg-A+ offering rules, it apparently has not yet reached its fundraising goal, since it’s extending …

The 15 Best THC Vape Pens

Are you looking for an alternative to the harsh, hack-inducing smoke produced by your joints, blunts, bongs, and Thai sticks? Try a THC vape pen instead.

In this article, we’ll tell you why many consider vaping to be a “safer” option than smoking. Then we’ll show you 15 of the best THC vape pens on the market to get you started. First, though, let’s discuss what vaping is and what it isn’t.

Vaping vs. Smoking

The product that eventually became known as the THC vape pen was first produced as an electronic cigarette to help tobacco smokers quit. It wasn’t long, though, before canny cannabis consumers recognized that these little devices could be used with marijuana as well.

And when they started modifying their electronic cigarettes to handle THC liquid, wax, and bud, they saw that the process of vaporizing was a great addition to the process of smoking joints or blunts.

Vaporizing is better than smoking because vaporizing reduces the temperature at which cannabinoids change from solid or liquid into gas.

This reduction in temperature preserves many of the active ingredients in marijuana—the stuff that gets you high and makes you feel good—that would otherwise have been destroyed when the cannabis was burned.

Think of it this way: a flame is pretty much only one temperature. It’s hot enough to burn your bud and turn it into smoke, which, for marijuana occurs at around 450℉.

But—and here’s the kicker—cannabinoids can be changed into a gas at much lower temperatures (around 284℉). All that extra heat is just destroying a large portion of the cannabinoids you’re trying to get into your system.

That’s where the THC vape pens come in. They operate at much lower temperatures than your common, everyday flame. Rather than producing smoke (through burning), they produce vapor (through vaporization).

As a result, you get more “bang for your buck” — or perhaps “cannabinoids for your

California Bureau of Cannabis Control accepting public comments on proposed rules

Members of the public are invited to provide comments on California’s proposed rules for cannabis businesses. The Bureau of Cannabis Control and other agencies seek public comments as they consider a permanent set of rules — replacing those temporarily in place.

For background, including the text of the proposed rules, summaries, and the agencies’ reasoning for seeking changes, visit the state’s website. Comments must be received by 5:00 p.m. on Monday, August 27.

For the most part, permanent rules would mirror those currently in place – but there are some key differences. A big improvement is a clarifying statement that adults 21 and older could receive cannabis deliveries at their own homes, statewide. This is a much-needed solution for those who live in parts of the state that have banned retail sales.

Unfortunately, the transition from illicit to legal sales has not gone as quickly as many had predicted in California, due in large part to rural communities that have refused to allow legal sales. By ensuring that deliveries are available for adults everywhere, consumers are given an option for safe, discreet, and legal sales.

Not all proposed rule changes are positive. One change would limit medical cannabis dispensaries to the sale of cannabis products and branded merchandise, preventing them from offering holistic health services such as counseling and support.

If you are a California resident, take a look at the proposed rules and be sure to send comments so they can be received before the deadline on the 27.

The post California Bureau of Cannabis Control accepting public comments on proposed rules appeared first on MPP Blog.

from https://blog.mpp.org/tax-and-regulate/california-bureau-of-cannabis-control-accepting-public-comments-on-proposed-rules/…

MPP has a new executive director!

We’re pleased to announce that Steve Hawkins has been named the new executive director of the Marijuana Policy Project. Steve brings three decades of experience fighting for criminal justice reform, having previously served in leadership roles at the NAACP, Amnesty International USA, and the Coalition for Public Safety.

The entire MPP staff is thrilled to welcome Steve to our organization.

Steve began his career as an attorney with the NAACP Legal Defense Fund challenging racial disparities in the criminal justice system. He later served as executive vice president of the NAACP, spearheading its efforts to end the police practice of “stop and frisk” in New York City and successfully encouraging the NAACP board of directors to adopt a policy in support of marijuana decriminalization. Steve also previously served as executive director of Amnesty International USA, as a program executive for the Atlantic Philanthropies, and as a senior program manager at the JEHT Foundation. You can read a more detailed biography here.

The marijuana reform movement has made incredible gains in the past several years but there’s still a great deal of work ahead. With Steve leading our experienced and talented team of reformers, and with your support, MPP will continue to enact medical marijuana and marijuana legalization laws that serve the interests of the American people.

The post MPP has a new executive director! appeared first on MPP Blog.

from https://blog.mpp.org/general/mpp-has-a-new-executive-director/…

MPP Names New Executive Director

Steve Hawkins: “I’m proud to join this incredible team of advocates at such a critical moment in the movement to end marijuana prohibition.”

Steve Hawkins is the Marijuana Policy Project’s new executive director. He replaces acting director Matthew Schweich, who took over for the organization’s co-founder and long time executive director Rob Kampia in December.

Hawkins previously held executive-level positions at the NAACP (executive vice president), Amnesty International USA (executive director) and the Coalition for Public Safety (president).

“The country is moving in the right direction on marijuana policy, but there’s still a lot of work to be done,” states MPP board chair Troy Dayton. “Steve is the perfect choice to oversee that work and lead MPP into the future.”

In a press release, Hawkins elaborated: “Throughout my career, I’ve witness the counterproductive efforts of the war on marijuana and its especially devastating impact on communities of color. I’m proud to join this incredible team of advocates at such a critical moment in the movement to end marijuana prohibition.”

During his time at Amnesty International, Hawklins drew criticism for steering the organization …

Vermont’s primary election is tomorrow

Check out our updated voter guides to learn where candidates for state legislature and governor stand on cannabis regulation!
The Vermont state primary election will be held tomorrow, Tuesday, August 14. If you are a Vermont resident and haven’t already voted, please check out our legislative voter guide to learn where candidates for state legislature stand on marijuana policy. Then, please read our guide on the candidates for governor.
This year, we sent candidates a survey consisting of only one question: “Do you support regulating and taxing the production and sale of cannabis in Vermont for use by adults 21 and older?” Our voter guides include responses from candidates for state representative, state senator, and governor, in addition to public statements and incumbent legislators’ votes on the legalization bill.
We have updated the gubernatorial voter guide to include a fifth candidate, state Sen. John Rodgers, who is running as a write-in candidate. At a recent public forum, all five Democratic candidates talked about their support for taxing and regulating cannabis.
For information on where and how to vote in Vermont, click here.

The post Vermont’s primary election is tomorrow appeared first on MPP Blog.

from https://blog.mpp.org/tax-and-regulate/vermonts-primary-election-is-tomorrow/…

Study: Cannabis Terpenes have “Anti-Inflammatory, Antioxidant, Analgesic, Anticonvulsive, Antidepressant, Anxiolytic, Anticancer, Antitumor, Neuroprotective, Anti-Mutagenic, Anti-Allergic, Antibiotic and Anti-Diabetic Attributes”

A new study has found that cannabis terpenes have attributes that are “anti-inflammatory, antioxidant, analgesic, anticonvulsive, antidepressant, anxiolytic, anticancer, antitumor, neuroprotective, anti-mutagenic, anti-allergic, antibiotic and anti-diabetic”.

The study was published by the European Journal of Medicinal Chemistry. It’s abstract starts by stating that “Cannabaceae plants Cannabis sativa L. and Humulus lupulus L. are rich in terpenes – both are typically comprised of terpenes as up to 3-5% of the dry-mass of the female inflorescence.” Some terpenes “are relatively well known for their potential in biomedicine and have been used in traditional medicine for centuries, while others are yet to be studied in detail.”

With that in mind, “The current, comprehensive review presents terpenes found in cannabis and hops.” They found that “Terpenes’ medicinal properties are supported by numerous in vitro, animal and clinical trials and show anti-inflammatory, antioxidant, analgesic, anticonvulsive, antidepressant, anxiolytic, anticancer, antitumor, neuroprotective, anti-mutagenic, anti-allergic, antibiotic and anti-diabetic attributes, among others.”

Researchers state that “Because of the very low toxicity, these terpenes are already widely used as food additives and in cosmetic products. Thus, they have been proven safe and well-tolerated.”

More information on this study can be found by clicking here.

The post Study: Cannabis Terpenes have “Anti-Inflammatory, Antioxidant, Analgesic, Anticonvulsive, Antidepressant, Anxiolytic, Anticancer, Antitumor, Neuroprotective, Anti-Mutagenic, Anti-Allergic, Antibiotic and Anti-Diabetic Attributes” appeared first on TheJointBlog.

from https://thejointblog.com/study-cannabis-terpenes-have-anti-inflammatory-antioxidant-analgesic-anticonvulsive-antidepressant-anxiolytic-anticancer-antitumor-neuroprotective-anti-mutagenic-anti-allergic-antibiotic/…

Study: Cannabis Can Help Treat Schizophrenia, Offering “a Fresh Start and Newfound Hope”

According to a new study published by the open access journal Medicines, and published online by the National Institute of Health, cannabis “can be used as a treatment for schizophrenia… offering a fresh start and newfound hope”.

According to the study’s abstract, “Approximately 0.5% of the population is diagnosed with some form of schizophrenia, under the prevailing view that the pathology is best treated using pharmaceutical medications that act on monoamine receptors.” For the study, researchers reviewed “evidence on the impact of environmental forces, particularly the effect of autoimmune activity, in the expression of schizophrenic profiles and the role of Cannabis therapy for regulating immunological functioning.”

“A review of the literature shows that phytocannabinoid consumption may be a safe and effective treatment option for schizophrenia as a primary or adjunctive therapy”, states the study. “Emerging research suggests that Cannabis can be used as a treatment for schizophrenia within a broader etiological perspective that focuses on environmental, autoimmune, and neuroinflammatory causes of the disorder, offering a fresh start and newfound hope for those suffering from this debilitating and poorly understood disease.”

The study was conducted at the University of New Mexico, with researchers from both the Department of Psychology and the Department of Economics.

The full study can be found by clicking here.

The post Study: Cannabis Can Help Treat Schizophrenia, Offering “a Fresh Start and Newfound Hope” appeared first on TheJointBlog.

from https://thejointblog.com/study-cannabis-can-help-treat-schizophrenia-offering-a-fresh-start-and-newfound-hope/…

It’s Official: North Dakota Marijuana Legalization Initiative Placed on November Ballot

An initiative to legalize marijuana in North Dakota has officially qualified for the November general election ballot.

According to the North Dakota secretary of state’s office, Legalize ND submitted more than the 13,500 valid signatures required to place their marijuana legalization initiative on the November 6 ballot.

The proposal, if passed, would give North Dakota one of the least restrictive legalization laws in the country. It would allow those 21 and older to possess, cultivate and distribute marijuana for recreational purposes. The initiative would legalize all forms of marijuana, including oils and hash,

In addition, the initiative establishes a 3-step system for marijuana expungements:

  • Step 1.) The state begins to analyze all those currently in prison with charges that would be applicable under the law and flags them for expungment.
  • Step 2.) 30 days after their release from prison, the state shall automatically expunge their records.
  • Step 3.) The state then has 10 additional days to send via certified mail notification of such an event occurring.

 

If that state fails to expunge a record that qualifies, the person has a right to a court appeal. If the person wins the court appeal, they can sue the state for fiscal damages with the state waiving it’s sovereign immunity in the case.

For more information on Legalize ND’s initiative, click here.

The post It’s Official: North Dakota Marijuana Legalization Initiative Placed on November Ballot appeared first on TheJointBlog.

from https://thejointblog.com/its-official-north-dakota-marijuana-legalization-initiative-placed-on-november-ballot/…

Study: Legalizing Medical Marijuana Associated with a 33.7% Reduction in Workplace Fatalities Among Those Aged 25 to 44

According to a new study published by the International Journal of Drug Policy, the legalization of medical marijuana is associated with a large decrease in workplace fatalities .

According to its abstract, the aim of the study “was to determine the association between legalizing medical marijuana and workplace fatalities.” Using data from all 50 states and the District of Columbia between 1992 and 2015 (obtained from the Bureau of Labor Statistics), regression models were adjusted for state demographics, the unemployment rate, state fixed effects, and year fixed effects.

“Legalizing medical marijuana was associated with a 19.5% reduction in the expected number of workplace fatalities among workers aged 25–44”, states the study. This associated “grew stronger over time”, rising to a 33.7% reduction five years after medical marijuana legalization took effect.

Researchers found that medical marijuana laws “that listed pain as a qualifying condition or allowed collective cultivation were associated with larger reductions in fatalities among workers aged 25–44 than those that did not.”

The association between legalizing medical marijuana and workplace fatalities among workers aged 16–24, “although negative, was not statistically significant at conventional levels.”

The study concludes by stating that :The results provide evidence that legalizing medical marijuana improved workplace safety for workers aged 25–44. Further investigation is required to determine whether this result is attributable to reductions in the consumption of alcohol and other substances that impair cognitive function, memory, and motor skills.

The full study can be found by clicking here.

The post Study: Legalizing Medical Marijuana Associated with a 33.7% Reduction in Workplace Fatalities Among Those Aged 25 to 44 appeared first on TheJointBlog.

from https://thejointblog.com/study-legalizing-medical-marijuana-associated-with-a-33-7-reduction-in-workplace-fatalities-among-those-aged-25-to-44/…

Marijuana Expected to be Rescheduled Federally by the Fall

Recently the United States Food and Drug Administration (FDA), for the first time ever, gave approval to a marijuana-based medicine. The company behind the medicine now says he expects the government to reschedule cannabis within 90 days.

“We expect to make Epidiolex available to U.S. patients this fall, following rescheduling which is expected to occur within 90 days of FDA approval,” said GW Pharmarceuticals’ CEO Justin Grover in a recent earnings call. “We have been building commercial inventory in recent months and are in a position to ship product into the U.S. supply chain, once rescheduling is complete.”

In June, Epidiolex became the first marijuana-derived medicine to ever be approved by the FDA. According to Grover, roughly 1,200 people in other countries are currently receiving Epidiolex, mostly for Lennox-Gastraut and Dravet Syndromes.

If rescheduling really does occur within 90 days of the FDA’s approval of Epidiolex, the change should happen by the end of September. The most likely scenario is that marijuana will be shifted to schedule 2, which means it’s still highly regulated but does have some medical value.

The post Marijuana Expected to be Rescheduled Federally by the Fall appeared first on TheJointBlog.

from https://thejointblog.com/marijuana-expected-to-be-rescheduled-federally-by-the-fall/…

Study: CBD Helps Heal Wounds During Their Early Stages

A new study published in the jounal Phytotherapy Research has found that CBD exerts “an antiinflammatory effect in early phase of wound healing process”.

“The effects of cannabidiol (CBD), the main non-psychotropic component of Cannabis sativa, were assessed on oral wound healing in an in vivo model”, states the abstract of the study, which was epublished ahead of print by the U.S. National Institute of Health. “Standardized ulcers” were induced in 60 rats, who subsequently received “intraperitoneal injections of CBD at doses of 0 (control), 5, and 10 mg/kg daily.” Animals were weighed daily, and wound healing was clinically and histologically evaluated after 3 and 7 days of treatment.

“CBD treatment did not influence the wound area of ulcerative lesions at either observation time”, states researchers. “”Conversely, microscopic findings revealed that at Day 3 postwounding, CBD-treated lesions exhibited significantly lower inflammatory scores than those in the control group.” However, “this difference was not observed at Day 7.”

Researchers conclude by stating that “Collectively, these findings indicate that CBD exert an antiinflammatory effect in early phase of wound healing process although it was not sufficient promote clinical improvement of oral traumatic ulcerative lesions.

The full study, conducted by researchers at Pontifical Catholic University of Rio Grande and the University of São Paulo, can be found by clicking here.

The post Study: CBD Helps Heal Wounds During Their Early Stages appeared first on TheJointBlog.

from https://thejointblog.com/study-cbd-helps-heal-wounds-during-their-early-stages/…

Nearly $600 million in Legal Marijuana Sold in Denver Last Year, $44 Million in Taxes Garnered

There was almost $600 million in marijuana and marijuana products sold in Denver in 2017, resulting in tens of million of dollars in taxes for the city.

According to a new report titled The Denver Collaborative Approach: Leading The Way In Municipal Marijuana Management 2018. there was roughly $587 million in legal marijuana sold throughout Denver in 2017, a 29% increase from the year prior. $377 million of this came from recreational marijuana sales, with the remaining $210 million from the legal distribution of medical marijuana

These sales resulted in around $44 million in taxes. This marks a 20% increase from the marijuana tax revenue the city garnered in 2016.

“This new report demonstrates Denver’s coordinated approach between multiple agencies to manage marijuana is working,” said Denver’s Mayor Michael B. Hancock in a press release sent out earlier today. “We took on the daunting challenge of becoming the first major city in America to manage legalized recreational marijuana and we are having success. That’s because of coordination between Denver’s Excise and Licenses, Denver’s Fire Department, Police Department, Department of Public Health and Environment, Community Planning and Development, as well as our partners in other city agencies, the community from the marijuana industry and public health advocates.”

In Denver, marijuana has been legal since 2013, with the first legal sales taking place in January of the following year.

Denver is the most populated city in Colorado with around 690,000 residents.

The post Nearly $600 million in Legal Marijuana Sold in Denver Last Year, $44 Million in Taxes Garnered appeared first on TheJointBlog.

from https://thejointblog.com/nearly-600-million-in-legal-marijuana-sold-in-denver-last-year-44-million-in-taxes-garnered/…

Connecticut primary election will take place Tuesday, August 14

Strong contrast emerges between Democratic candidates for attorney general

The Connecticut primary election will take place next Tuesday, August 14. If you’re a Connecticut resident and you’re not sure how or where to vote, please visit the secretary of state’s website for more information.

On the Democratic ticket, both candidates for governor and both candidates for lieutenant governor have said they support taxing and regulating marijuana. However, in the race for attorney general, there is a strong contrast between the Democratic candidates’ positions. At a recent debate, former U.S. Attorney Chris Mattei spoke strongly in favor of regulating marijuana, while the other two candidates, state Rep. William Tong and state Sen. Paul Doyle, “expressed reservations.” Additionally, Mattei has criticized Tong for his failure to support the medical cannabis bill when it passed in 2012.

None of the five Republican candidates for governor have spoken publicly in favor of ending marijuana prohibition.

The post Connecticut primary election will take place Tuesday, August 14 appeared first on MPP Blog.

from https://blog.mpp.org/tax-and-regulate/connecticut-primary-election-will-take-place-tuesday-august-14/…

Study: 80% of Autistic Children Saw Improvements Afer Consuming CBD

In a new study published by the journal Neurology, 80% of children with autism saw improvements in their condition after being administered cannabidiol (CBD).

For the study, 60 children with an average age of 12 were given cannabis oil containing 20% CBD and 1% THC, for a period of seven months.

After the seven-month period, children filled out a questionnaire asking  if they noticed any changes in their condition. Parents were asked if they noticed any changes in their child’s condition, and were asked about any changes in their child’s anxiety levels and communication abilities.

According to the study’s lead Dr. Adi Aran, director of the pediatric neurology unit at Shaare Zedek Hospital in Jerusalem, 80% of parents reported a decrease in problematic behavior following the use of CBD, and 62% reported that their child’s behavior improved significantly. Around half of the children claimed they noticed improvements in their communication, and 40% saw significant improvements in their anxiety symptoms.

“According to the astonishing report, eighty percent of the children reported improved functioning!”, says Nachshol Cohen, Founder of Cannabium. “We hope that this research will help to bring about a conceptual change by regulators and policymakers, which will lead to a scientific momentum that will unequivocally demonstrate the positive effects of cannabis on a variety of health problems.”

The study also found that half of the children who participated in the study also reported an improvement in their level of communication, with 40% saying that their anxiety symptoms had significantly improved. A third of the participants did not show symptoms of anxiety before the study began.

The post Study: 80% of Autistic Children Saw Improvements Afer Consuming CBD appeared first on TheJointBlog.

from https://thejointblog.com/study-80-of-autistic-children-saw-improvements-afer-consuming-cbd/…

Florida Judge Rules Limit on Medical Cannabis Businesses is Unconstitutional

A circuit court judge in Florida has ruled that the state’s limit on medical cannabis businesses is unconstitutional as it runs contrary to the intent of the voter-approved initiative that legalized the medicine.

Leon County Circuit Judge Charles Dodson ruled that an arbitrary cap on medical marijuana treatment centers, passed by state lawmakers in 2017, “directly contradicts the amendment” that legalized medical cannabis.

“Such limits directly undermine the clear intent of the amendment, which by its language seeks to prevent arbitrary restriction on the number of MMTCs authorized to conduct business in the state”, Dodson wrote in his ruling. “The amendment mandates the availability and safe use of medical marijuana by qualifying patients”.

Dodson also ruled that the state’s requirement of “vertical integration” is unconstitutional.

“It’s the first time any judge has weighed in on the licensing process at all, and what he said was unequivocal”, says Florigrown CEO Adam Eland. “What he’s saying, and I think this is super clear, is what you’re doing is unconstitutional”.

The post Florida Judge Rules Limit on Medical Cannabis Businesses is Unconstitutional appeared first on TheJointBlog.

from https://thejointblog.com/florida-judge-rules-limit-on-medical-cannabis-businesses-is-unconstitutional/…

California: Medical Cannabis for Pets Bill Passed by Assembly, Advances in Senate

Legislation to explicitly allow and regulate the medical use of cannabis for pets is advancing in the California Legislature.

California Assembly Bill 2215 would expand “the intent of the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) to control and regulate cannabis and cannabis products for medicinal use on pets.” The bill would define “cannabis products” to include products intended for medicinal use on a pet. The bill wouldn’t allow a veterinarian to administer medical cannabis, “but allow a veterinarian to discuss the use of cannabis on an animal for medicinal purposes without being disciplined or denied, revoked or suspended by the Veterinary Medical Board (VMB). ”

The measure states that the VMB “would have until July 1, 2019 to promulgate guidelines for veterinarians to follow when discussing the use of cannabis”, and it “Provides that a cannabis product for use on a pet may only be sold to an adult 21 years or age or over by a licensee who has been issued a retailer license, as specified.”

The proposal quietly passed the Assembly at the end of May in a 60 to 10 vote. Yesterday in the Senate Appropriations Committee it was “ordered to second reading pursuant to Senate Rule 28.8.”

If the bill is passed by the full Senate, it will be sent to Governor Jerry Brown for consideration.

The full text of Assembly Bill 2215 can be found by clicking here.

The post California: Medical Cannabis for Pets Bill Passed by Assembly, Advances in Senate appeared first on TheJointBlog.

from https://thejointblog.com/california-medical-cannabis-for-pets-bill-passed-by-assembly-advances-in-senate/…

Proposed US Tariffs Threaten Vaporizer Industry

The Blinc Group’s Arnaud d Dumas Rauly: “The cannabis industry will suffer from these tariffs.”

The US vaporizer industry is in a panic over proposed 25% tariffs on Chinese products. This would affect pen devices, hardware and batteries. China dominates the worldwide vaporizer hardware market.

“The rationale behind this administration’s trade war against China is twofold: stealing American jobs and stealing American IP and know-how,” Arnaud Dumas de Rauly, co-founder and co-CEO of the New York-based vape company, The Blinc Group, tells Freedom Leaf. “However, as it pertains to vaping products, none of these jobs and know-how are in the US to begin with. The cannabis industry will suffer from these tariffs.

“The supply of raw material isn’t big enough in the US to support a switch to US manufacturing,” he continues. “The skillsets aren’t in the US either. Bottom line, these tariffs will not bring jobs to America. In addition, given the small margins (10-15%) on the hardware, the cost of these tariffs will be passed on to consumers, which will limit patient/consumer access to cannabis products, especially in states like Florida and New York, whose medical programs relay on vaping products. Finally, the regulatory uncertainty is already stifling the cannabis industry, so this trade war will be adding ‘federal action’ onto already struggling businesses. It just doesn’t make sense, not to mention the loss of taxes on a state level that will result from the limited access.”

ARNAUD DE DUMAS RAULY: “These proposed tariff increases will do great harm to American businesses, medical marijuana patients and adult use consumers.”

On July 24, Dumas de Rauly testified at public hearings conducted by The Office of the U.S. Trade Representative regarding proposed tariffs on $16 billion worth of Chinese products.

Report: Drug Legalization Would Add $100 Billion to U.S. Budget

Ending the drug war would result in an additional $100 billion annually for the U.S. budget, according to a new report conducted by The Cato Institute.

“Drawing on the most recent available data, this bulletin estimates the fiscal windfall that would be achieved through drug legalization”, states the report. “All told, drug legalization could generate up to $106.7 billion in annual budgetary gains for federal, state, and local governments.” Those gains would come from two primary sources: decreases in drug enforcement spending and increases in tax revenue.

The report estimates that “state and local governments spend $29 billion on drug prohibition annually, while the federal government spends an additional $18 billion.” Meanwhile, “full drug legalization would yield $19 billion in state and local tax revenue and $39 billion in federal tax revenue.

“Legalization can reduce government spending, which saves resources for other uses, and it generates tax revenue that transfers income from drug producers and consumers to public coffers,”  Jeffrey Miron, the institute’s Director of Economic Studies, states in the report.

The full report can be found by clicking here.

The post Report: Drug Legalization Would Add $100 Billion to U.S. Budget appeared first on TheJointBlog.

from https://thejointblog.com/report-drug-legalization-would-add-100-billion-to-u-s-budget/…

Rohrabacher Received Campaign Donations from Manafort, Had Meetings with Assange and Butina

Rep. Dana Rohrabacher (R-Calif.) may be a friend to marijuana legalization, but that’s where his liberal leanings stop. The Congressman is a major backer of Donald Trump and has been implicated in Russian meddling in the 2016 presidential campaign.

Though his name has not been mentioned so far in special counsel Robert Mueller’s investigation into Russia’s interference in the election, it’s now known that Rohrabacher attended a 2013 meeting with former Trump campaign chairman Paul Manafort, who’s been indicted by the special counsel.

Rohrabacher, Manafort and former Rep. Vin Weber, a Minnesota Republican who’s now a lobbyist with Mercury, were at the meeting on Mar. 19, 2013, which was disclosed in retroactive filings with the Justice Department last year that detailed Manafort and Rick Gates’ work for the European Center for a Modern Ukraine. Gates, a former Trump campaign aide and Manafort associate, pled guilty on Feb. 23 to felony charges of conspiracy and making false statements in a plea bargain with Mueller.

Gates lied about the 2013 meeting and his Ukraine-related work with Manafort. He’s charged with “admitting to take part in a conspiracy to hide tens of millions of dollars that he and former Trump campaign chairman Paul Manafort obtained from their consulting work related to Ukraine.” Gates later helped Manafort prepare “a report that memorialized for Ukrainian leadership the pertinent Ukraine discussions that Manafort represented had taken place at the meeting.”

Illinois Governor Signs Bill Allowing Medical Cannabis to be Consumed at Schools

Illinois Governor Bruce Rauner has signed into law a bill allowing students who are medical cannabis patients to use their medicine on school premises.

Governor Rauner’s signing of House Bill 4870 comes roughly two and a half months after the legislature passed the measure by a vote of 149 to 3.

The legislation is known as Ashley’s Law, named after 12-year-old Ashley Surin who uses medical marijuana to treat the epilepsy she developed during chemotherapy. The  bill amends the Illinois School Code to require “a school district, public school, charter school, or nonpublic school to authorize a parent or guardian of a student who is a qualifying patient to administer a medical cannabis infused product to the student on school premises or a school bus if both the student (as a qualifying patient) and the parent or guardian (as a designated caregiver) have been issued registry identification cards under the Compassionate Use of Medical Cannabis Pilot Program Act.”

The measure  “Provides that a parent or guardian may not administer a medical cannabis infused product if the administration would create disruption to the school’s educational environment or would cause exposure of the product to other students”, and “Provides that nothing in the provision requires a member of the school’s staff to administer a medical cannabis infused product to a student.”

An amendment  passed by the House states:

Provides that the provision may be referred to as Ashley’s Law. Defines terms. Provides that, in addition to the parent or guardian of a student who is a registered qualifying patient, an individual registered with the Department of Public Health as a designated caregiver may administer a medical cannabis infused product to that student. Makes conforming changes. Provides that a parent or guardian or other individual may not administer a medical cannabis infused product in a manner that, in the opinion of the school district or school, would create a disruption to the

Illinois Governor Signs Bill Allowing Medical Cannabis to be Consumed at Schools

Illinois Governor Bruce Rauner has signed into law a bill allowing students who are medical cannabis patients to use their medicine on school premises.

Governor Rauner’s signing of House Bill 4870 comes roughly two and a half months after the legislature passed the measure by a vote of 149 to 3.

The legislation is known as Ashley’s Law, named after 12-year-old Ashley Surin who uses medical marijuana to treat the epilepsy she developed during chemotherapy. The  bill amends the Illinois School Code to require “a school district, public school, charter school, or nonpublic school to authorize a parent or guardian of a student who is a qualifying patient to administer a medical cannabis infused product to the student on school premises or a school bus if both the student (as a qualifying patient) and the parent or guardian (as a designated caregiver) have been issued registry identification cards under the Compassionate Use of Medical Cannabis Pilot Program Act.”

The measure  “Provides that a parent or guardian may not administer a medical cannabis infused product if the administration would create disruption to the school’s educational environment or would cause exposure of the product to other students”, and “Provides that nothing in the provision requires a member of the school’s staff to administer a medical cannabis infused product to a student.”

An amendment  passed by the House states:

Provides that the provision may be referred to as Ashley’s Law. Defines terms. Provides that, in addition to the parent or guardian of a student who is a registered qualifying patient, an individual registered with the Department of Public Health as a designated caregiver may administer a medical cannabis infused product to that student. Makes conforming changes. Provides that a parent or guardian or other individual may not administer a medical cannabis infused product in a manner that, in the opinion of the school district or school, would create a disruption to the

Study: THC May Treat Agitation In Alzheimer’s Patients

The administration of nabilone, a synthetic compound meant to mimic the effects of  natural THC, reduces agitation and other behavioral symptoms in Alzheimer’s patients, according to new research.

“Results of a randomized, double-blind clinical trial suggest that nabilone — a synthetic cannabinoid — may be effective in treating agitation in people with Alzheimer’s disease”, states a press release for the study, which was presented at the Alzheimer’s Association International Conference (AAIC) 2018.

“Agitation, including verbal or physical outbursts, general emotional distress, restlessness, pacing, is one of the most common behavioral changes associated with Alzheimer’s as it progresses, and can be a significant cause of caregiver stress,” said Krista L. Lanctôt, PhD, Senior Scientist at Sunnybrook Health Sciences Centre and Professor of Psychiatry and Pharmacology/Toxicology at the University of Toronto.

Lanctôt and colleagues investigated the potential benefits of nabilone for adults with moderate to severe Alzheimer’s dementia with clinically significant agitation. Over the 14-week trial duration, 39 participants (77 percent male, average age 87) received nabilone in capsule form (mean therapeutic dose=1.6 +/- .5 mg) for six weeks, followed by six weeks of placebo, with one week between each treatment period. In addition to measuring agitation, the researchers assessed overall behavioral symptoms, memory, physical changes and safety. They found that:

  • Agitation improved significantly in those taking nabilone, compared to placebo, as measured by the Cohen-Mansfield Agitation Inventory (p=0.003).
  • Nabilone also significantly improved overall behavioral symptoms, compared to placebo, as measured by the Neuropsychiatric Inventory (p=0.004).

 

The researchers also observed small benefits in cognition and nutrition during the study. More people in the study experienced sedation on nabilone (45 percent) compared to placebo (16 percent).

“Currently prescribed treatments for agitation in Alzheimer’s do not work in everybody, and when they do work the effect is small and they increase risk of harmful side effects, including increased risk of death. As a result, there is an urgent need …

Alaska Garnered Over $11 Million in Taxes from Legal Marijuana Sales in FY 2018

According to data released by the Alaska Department of Revenue, the state earned over $11 million in taxes from the sale of marijuana and marijuana products in FY 2018.

In total, Alaska made $11,094,808 in tax revenue from marijuana sales during FY (fiscal year) 2018. This surpasses the Department of Revenue’s predictions for the year by around $2 million.

The highest earning month for FY 2018, which began on July 1, 2017 with the final day being June 31 of this year, was June with $1,257,513 in marijuana taxes brought  in. The lowest month was July at $577,901.

In Alaska, marijuana was legalized through a citizen’s initiative in 2014, with those 21 and  older allowed to purchase, possess and use up to an ounce (with the possession limit rising to four ounces when in a private residence). The state’s first licensed marijuana retail outlet opened nearly two years later in October, 2016.

Under the state’s law, marijuana is taxed at $50 per ounce for bud, and $15 per ounce for leaves and other trimmings.

The post Alaska Garnered Over $11 Million in Taxes from Legal Marijuana Sales in FY 2018 appeared first on TheJointBlog.

from https://thejointblog.com/alaska-garnered-over-11-million-in-taxes-from-legal-marijuana-sales-in-fy-2018/…